Juno And Celgene Announce Partnership To Create Immunotherapy Drugs; AH, One Stock Zooms
June 29, 2015 at 20:22 PM EDT
Shares of Juno are up 38% after hours after it announced a 10-year collaboration with Celgene to develop immunotherapies for cancer and auto-immune diseases. Celgene is slightly down.
